Skip to main content

Table 1 Clinical characteristics of type 1 g-NEN patients and control participants

From: Circulating miRNA-202-3p is a potential novel biomarker for diagnosis of type 1 gastric neuroendocrine neoplasms

Variable

Patient group (n = 27)

Control group (n = 27)

p

Male/female (n/n)

6/21

6/21

Age (years)

56 (52, 63)

52 (50, 57)

0.191